Maryland Capital Advisors’s AbbVie ABBV Stock Holding History

Maryland Capital Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$242K	Buy	+963	New	+$207K	0.08%	82
2025 Q4	$226K	Buy	987 +26	+3%	+$5.92K	0.08%	81
2025 Q3	$223K	Hold	961	–	–	0.08%	80
2025 Q2	$178K	Buy	961 +661	+220%	+$123K	0.07%	81
2025 Q1	$62.9K	Hold	300	–	–	0.03%	112
2024 Q4	$53.3K	Hold	300	–	–	0.02%	123
2024 Q3	$59.2K	Hold	300	–	–	0.03%	112
2024 Q2	$51.5K	Hold	300	–	–	0.03%	114
2024 Q1	$54.6K	Hold	300	–	–	0.03%	106
2023 Q4	$46.5K	Hold	300	–	–	0.03%	109
2023 Q3	$44.7K	Hold	300	–	–	0.03%	110
2023 Q2	$40.4K	Hold	300	–	–	0.03%	112
2023 Q1	$47.8K	Hold	300	–	–	0.04%	105
2022 Q4	$48.5K	Sell	300 -66	-18%	-$10.1K	0.05%	104
2022 Q3	$49K	Hold	366	–	–	0.05%	91
2022 Q2	$56K	Buy	366 +66	+22%	+$10.1K	0.06%	87
2022 Q1	$49K	Hold	300	–	–	0.04%	91
2021 Q4	$41K	Buy	+300	New	+$35.4K	0.03%	98

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Maryland Capital Advisors's ABBV Position: Q2 2026 in Review

Maryland Capital Advisors opened a new position in AbbVie (ABBV) in Q2 2026: 963 shares worth $242K. The stake represents 0.08% of the portfolio and ranks #82 among its holdings. This is a return to the name: Maryland Capital Advisors previously reported a position in ABBV as recently as Q4 2025.

Maryland Capital Advisors first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Maryland Capital Advisors held 963 shares of AbbVie worth $242K as of Q2 2026.
AbbVie was a new Maryland Capital Advisors position in Q2 2026.
AbbVie made up 0.08% of Maryland Capital Advisors's portfolio in Q2 2026, its #82 holding.
Maryland Capital Advisors first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Maryland Capital Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.